Thomas K Equels - 11 Nov 2021 Form 4 Insider Report for AIM ImmunoTech Inc. (AIMI)

Role
CEO & President, Director
Signature
Thomas K. Equels
Issuer symbol
AIMI
Transactions as of
11 Nov 2021
Net transactions value
$0
Form type
4
Filing time
15 Nov 2021, 15:57:48 UTC
Previous filing
16 Jul 2021
Next filing
17 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AIM Options Award $0 +300,000 $0.000000 300,000 11 Nov 2021 Common Stock 300,000 $1.71 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.